Benjamin L. Palleiko

Insider Reports History

Location: Cambridge, MA
Signature: /s/ Benjamin L. Palleiko
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Benjamin L. Palleiko:

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

KalVista Pharmaceuticals, Inc.

Security class: Common Stock
Shares / value: 467,665
Estimated value: $12,514,715
Report date: 18 May 2026
Price: $26.76
Ownership: Direct

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

KalVista Pharmaceuticals, Inc.

Security class: Restricted Stock Unit
Shares / value: 0
Estimated value: $1,878,760
Report date: 17 May 2026
Price: $10.02
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

KalVista Pharmaceuticals, Inc.

Security class: Employee Stock Option
Shares / value: 113,920
Estimated value
Report date: 11 Aug 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Benjamin L. Palleiko

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 17 May 2026
Transactions: 3
Transaction value: -$30,212
Filing time: 19 May 2026, 16:03
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 11 May 2026
Transactions: 3
Transaction value: -$88,731
Filing time: 13 May 2026, 16:25
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 16 Apr 2026
Transactions: 3
Transaction value: -$193,066
Filing time: 20 Apr 2026, 19:40
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 06 Mar 2026
Transactions: 3
Transaction value: -$107,633
Filing time: 10 Mar 2026, 18:47
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 21 Feb 2026
Transactions: 3
Transaction value: -$156,197
Filing time: 24 Feb 2026, 19:44
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 17 Feb 2026
Transactions: 3
Transaction value: -$15,570
Filing time: 19 Feb 2026, 19:45
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 11 Feb 2026
Transactions: 3
Transaction value: -$52,658
Filing time: 13 Feb 2026, 16:05
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 16 Jan 2026
Transactions: 1
Transaction value: $0
Filing time: 21 Jan 2026, 16:09
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 06 Dec 2025
Transactions: 3
Transaction value: -$120,424
Filing time: 09 Dec 2025, 18:16
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 21 Nov 2025
Transactions: 3
Transaction value: -$147,154
Filing time: 26 Nov 2025, 18:46
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 17 Nov 2025
Transactions: 4
Transaction value: -$64,665
Filing time: 19 Nov 2025, 16:13
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 11 Nov 2025
Transactions: 3
Transaction value: -$38,438
Filing time: 13 Nov 2025, 16:28
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 06 Sep 2025
Transactions: 3
Transaction value: -$115,537
Filing time: 09 Sep 2025, 19:02
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 21 Aug 2025
Transactions: 3
Transaction value: -$144,657
Filing time: 25 Aug 2025, 19:46
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 17 Aug 2025
Transactions: 4
Transaction value: -$58,141
Filing time: 19 Aug 2025, 16:26
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 11 Aug 2025
Transactions: 2
Transaction value: $0
Filing time: 13 Aug 2025, 17:29
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 08 Jul 2025
Transactions: 2
Transaction value: -$517,523
Filing time: 10 Jul 2025, 20:56
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 06 Jun 2025
Transactions: 3
Transaction value: -$103,950
Filing time: 10 Jun 2025, 17:00
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 21 May 2025
Transactions: 3
Transaction value: -$118,743
Filing time: 23 May 2025, 16:24
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 17 May 2025
Transactions: 4
Transaction value: -$45,097
Filing time: 20 May 2025, 19:28
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 06 Mar 2025
Transactions: 3
Transaction value: -$79,828
Filing time: 10 Mar 2025, 18:43
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 21 Feb 2025
Transactions: 1
Transaction value: $0
Filing time: 25 Feb 2025, 20:36
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 17 Feb 2025
Transactions: 4
Transaction value: -$50,143
Filing time: 19 Feb 2025, 20:46
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 06 Dec 2024
Transactions: 3
Transaction value: -$74,363
Filing time: 09 Dec 2024, 21:08
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 17 Nov 2024
Transactions: 5
Transaction value: -$133,294
Filing time: 19 Nov 2024, 19:19
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 06 Sep 2024
Transactions: 3
Transaction value: -$89,622
Filing time: 10 Sep 2024, 20:31
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 17 Aug 2024
Transactions: 5
Transaction value: -$170,769
Filing time: 21 Aug 2024, 21:25
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 06 Jun 2024
Transactions: 3
Transaction value: -$86,068
Filing time: 10 Jun 2024, 18:42
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 17 May 2024
Transactions: 6
Transaction value: -$258,337
Filing time: 21 May 2024, 17:57
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 06 Mar 2024
Transactions: 1
Transaction value: $0
Filing time: 08 Mar 2024, 16:50
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 17 Feb 2024
Transactions: 6
Transaction value: -$321,846
Filing time: 21 Feb 2024, 21:46
Role: CFO, CBO
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 14 Feb 2024
Transactions: 1
Transaction value: -$613,205
Filing time: 16 Feb 2024, 16:21
Role: CFO, CBO
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 11 Feb 2024
Transactions: 2
Transaction value: $0
Filing time: 13 Feb 2024, 09:23
Role: CFO, CBO
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 17 Nov 2023
Transactions: 5
Transaction value: -$107,047
Filing time: 21 Nov 2023, 16:31
Role: President, CFO, CBO & Sec'y
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 17 Aug 2023
Transactions: 5
Transaction value: -$140,192
Filing time: 21 Aug 2023, 20:05
Role: President, CFO, CBO & Sec'y
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 18 May 2023
Transactions: 1
Transaction value: $0
Filing time: 22 May 2023, 21:33
Role: President, CFO, CBO & Sec'y
Next action: Open filing details

4/A KALV

KalVista Pharmaceuticals, Inc.

Report period: 17 Feb 2023
Transactions: 1
Transaction value: $0
Filing time: 22 May 2023, 21:39
Role: President, CFO, CBO & Sec'y
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 11 Jan 2023
Transactions: 5
Transaction value: -$40,953
Filing time: 19 May 2023, 21:19
Role: President, CFO, CBO & Sec'y
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 17 Nov 2022
Transactions: 3
Transaction value: -$3,928
Filing time: 21 Nov 2022, 15:20
Role: CFO, CBO & Secretary
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 17 Aug 2022
Transactions: 3
Transaction value: -$10,847
Filing time: 19 Aug 2022, 17:15
Role: CFO, CBO & Secretary
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 17 May 2022
Transactions: 2
Transaction value: $0
Filing time: 19 May 2022, 16:56
Role: CFO, CBO & Secretary
Next action: Open filing details

4 KALV

KalVista Pharmaceuticals, Inc.

Report period: 26 May 2021
Transactions: 1
Transaction value: $0
Filing time: 28 May 2021, 17:25
Role: CFO, CBO & Secretary
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .